The use of the weight-loss drug Wegovy has increased by 50% among teenagers in the United States, reflecting a worsening obesity crisis. Reports indicate a significant rise in adolescent prescriptions for Wegovy, with many young Americans turning to this medication as a solution for weight management. Novo Nordisk, the company behind Wegovy, has noted this surge in demand, highlighting a growing trend in the use of weight-loss drugs among American youth.